Subscribe Now Subscribe Today
Science Alert
 
Blue
   
Curve Top
Journal of Pharmacology and Toxicology
  Year: 2007 | Volume: 2 | Issue: 7 | Page No.: 653-659
DOI: 10.3923/jpt.2007.653.659
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Effect of Combined Paracetamol and Cuminum cyminum or Nigella sativa Use in Wistar Rats

Einas M. Elhabib, M.M.A. Homeida and S.E.I. Adam

Abstract:
Cuminum cyminum fruit or Nigella sativa seed, a traditional medicine for treatment of various disorders, was fed to male Wistar rats at 6% of standard rat diet for 4 weeks. A 6% C. cyminum fruit or 6% N. sativa seed diet was not toxic to rats. Depression in growth, hepatotoxicity and nephrotoxicity were observed in rats that had been given paracetamol at 500 mg kg-1 per os for 4 weeks. These findings were accompanied by leucopenia, macrocytic normochromic anemia and alterations of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP) activities and concentrations of cholesterol, urea and other serum constituents. Serum bilirubin did not change. In rats given the mixture of paracetamol 500 mg kg-1 plus 6% C. cyminum fruit or 6% N. sativa seed for 4 weeks, the recovery of paracetamol hepatotoxicity was evidenced by increase in body weight, absence of hepatocellular fatty vacuolation and significant improvement of serbiochemical and hematological parameters. There was no evidence of any antinephrotoxic activity of plants used.
PDF Fulltext XML References Citation Report Citation
 RELATED ARTICLES:
  •    Evaluation of Toxicological Activity (Acute and Sub-Chronic Toxicities) of the Aqueous Extract of Lawsonia inermis Seeds on Wistar Rats
How to cite this article:

Einas M. Elhabib, M.M.A. Homeida and S.E.I. Adam , 2007. Effect of Combined Paracetamol and Cuminum cyminum or Nigella sativa Use in Wistar Rats. Journal of Pharmacology and Toxicology, 2: 653-659.

DOI: 10.3923/jpt.2007.653.659

URL: https://scialert.net/abstract/?doi=jpt.2007.653.659

COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 

Curve Bottom